Tranexamic Acid manufacturers & suppliers

Tranexamic Acid

Form: Intravenous (IV) injection

Strength: 100 mg/mL in 5 mL, 10 mL, or 100 mL vials

Reference Brands: Cyklokapron®(US & EU)

Category: Critical Care

Tranexamic Acid is an antifibrinolytic agent used to reduce or prevent excessive bleeding in surgical, trauma, and gynecological settings. Available in IV and oral forms, it is commonly supplied as 100 mg/mL injection or 500 mg tablets. Leading brands include Cyklokapron® (Pfizer), Lysteda® (Ferring), and Exacyl® (Sanofi). Widely adopted in both emergency medicine and elective surgeries, tranexamic acid helps stabilize clots and minimize transfusion needs. Pharma B2B platforms provide access to GMP-certified tranexamic acid products in bulk quantities, supporting hospitals, surgical centers, and emergency care providers with reliable global sourcing and compliance with US and EU pharmaceutical standards.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Glucagon

Strength: 1 mg lyophilized powder for reconstitution (IM/SC/IV)

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection

Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)

View Details
Insulin (Iv)

Strength: 100 units/mL (U-100) in 10 mL vials

Form: Intravenous (IV) solution

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

View Details
Flumazenil

Strength: 0.1 mg/mL in 5 mL or 10 mL vials

Form: Intravenous (IV) injection

Reference Brands: Romazicon®(US), Anexate®(EU)

View Details
Naloxone

Strength: 0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes

Form: Intravenous (IV) injection/IM/SQ

Reference Brands: Narcan® (US); Narcan® (EU)

View Details

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

We use cookies to ensure you get the best experience. Learn more